{"id":"https://openalex.org/W2054913636","doi":"https://doi.org/10.1158/1078-0432.ccr-14-0341","title":"Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS\u2013RAF Mutations","display_name":"Phase I Expansion and Pharmacodynamic Study of the Oral MEK Inhibitor RO4987655 (CH4987655) in Selected Patients with Advanced Cancer with RAS\u2013RAF Mutations","alternate_titles":[],"publication_year":2014,"publication_date":"2014-08-13","ids":{"openalex":"https://openalex.org/W2054913636","doi":"https://doi.org/10.1158/1078-0432.ccr-14-0341","mag":"2054913636","pmid":"https://pubmed.ncbi.nlm.nih.gov/24947927"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-14-0341","doi":"https://doi.org/10.1158/1078-0432.ccr-14-0341","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-14-0341","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2054913636"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064923908","display_name":"Lisa Zimmer","orcid":"https://orcid.org/0000-0002-3680-3521","observed_orcids":["https://orcid.org/0000-0002-3680-3521"]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lisa Zimmer","raw_affiliation_strings":["1Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087836238","display_name":"Fabrice Barl\u00e9si","orcid":"https://orcid.org/0000-0001-5793-3539","observed_orcids":["https://orcid.org/0000-0001-5793-3539"]},"institutions":[{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]},{"id":"https://openalex.org/I4210087487","display_name":"Assistance Publique H\u00f4pitaux de Marseille","ror":"https://ror.org/002cp4060","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fabrice Barlesi","raw_affiliation_strings":["2Aix Marseille University, Assistance Publique H\u00f4pitaux de Marseille, Phase I unit, CIC- CPCET, Marseille, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Aix Marseille University, Assistance Publique H\u00f4pitaux de Marseille, Phase I unit, CIC- CPCET, Marseille, France","institution_ids":["https://openalex.org/I21491767","https://openalex.org/I4210087487"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037165485","display_name":"Maria Martinez\u2010Garc\u00eda","orcid":"https://orcid.org/0000-0001-5891-3935","observed_orcids":["https://orcid.org/0000-0001-5891-3935"]},"institutions":[{"id":"https://openalex.org/I4210130874","display_name":"Hospital Del Mar","ror":"https://ror.org/03a8gac78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210130874"]},{"id":"https://openalex.org/I4210136145","display_name":"Municipal Institute for Medical Research","ror":"https://ror.org/039evc422","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210136145"]},{"id":"https://openalex.org/I4210156109","display_name":"Hospital del Mar Research Institute","ror":"https://ror.org/042nkmz09","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210156109","https://openalex.org/I4387153040"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Maria Martinez-Garcia","raw_affiliation_strings":["3Department of Medical Oncology, Hospital del Mar and Cancer Research Program, IMIM, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Hospital del Mar and Cancer Research Program, IMIM, Barcelona, Spain","institution_ids":["https://openalex.org/I4210130874","https://openalex.org/I4210136145","https://openalex.org/I4210156109"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056565799","display_name":"Veronique C Dieras","orcid":"https://orcid.org/0000-0001-8094-4738","observed_orcids":["https://orcid.org/0000-0001-8094-4738","https://orcid.org/0000-0002-8798-6540"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Veronique Dieras","raw_affiliation_strings":["4Institute Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Institute Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000418012","display_name":"Jan H.M. Schellens","orcid":"https://orcid.org/0000-0001-6832-1976","observed_orcids":["https://orcid.org/0000-0001-6832-1976"]},"institutions":[{"id":"https://openalex.org/I2898336195","display_name":"The Netherlands Cancer Institute","ror":"https://ror.org/03xqtf034","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2898336195"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jan H.M. Schellens","raw_affiliation_strings":["5The Netherlands Cancer Institute, Amsterdam, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5The Netherlands Cancer Institute, Amsterdam, the Netherlands","institution_ids":["https://openalex.org/I2898336195"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020254907","display_name":"Jean\u2010Philippe Spano","orcid":"https://orcid.org/0000-0002-3921-2479","observed_orcids":["https://orcid.org/0000-0002-3921-2479"]},"institutions":[{"id":"https://openalex.org/I4210121705","display_name":"Piti\u00e9-Salp\u00eatri\u00e8re Hospital","ror":"https://ror.org/02mh9a093","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210121705"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Philippe Spano","raw_affiliation_strings":["6H\u00f4pital La Piti\u00e9-Salp\u00eatri\u00e8re, IUC/UPMC, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6H\u00f4pital La Piti\u00e9-Salp\u00eatri\u00e8re, IUC/UPMC, Paris, France","institution_ids":["https://openalex.org/I4210121705","https://openalex.org/I4405264447"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051430596","display_name":"Mark Ross Middleton","orcid":"https://orcid.org/0000-0003-0167-1685","observed_orcids":["https://orcid.org/0000-0003-0167-1685"]},"institutions":[{"id":"https://openalex.org/I2801179840","display_name":"Churchill Hospital","ror":"https://ror.org/009vheq40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801179840","https://openalex.org/I4210147381"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mark R. Middleton","raw_affiliation_strings":["7Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, United Kingdom","institution_ids":["https://openalex.org/I2801179840"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053069942","display_name":"Emiliano Calvo","orcid":"https://orcid.org/0000-0003-4921-829X","observed_orcids":["https://orcid.org/0000-0003-4921-829X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Emiliano Calvo","raw_affiliation_strings":["8START Madrid, Hospital Universitario Madrid Sanchinarro, Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8START Madrid, Hospital Universitario Madrid Sanchinarro, Madrid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083563755","display_name":"Luiz Paz-Ares","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Luiz Paz-Ares","raw_affiliation_strings":["9Hospital Virgen del Rocio, Seville, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Hospital Virgen del Rocio, Seville, Spain","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076054848","display_name":"James Larkin","orcid":"https://orcid.org/0000-0001-5569-9523","observed_orcids":["https://orcid.org/0000-0001-5569-9523"]},"institutions":[{"id":"https://openalex.org/I1325846038","display_name":"Royal Marsden NHS Foundation Trust","ror":"https://ror.org/0008wzh48","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James Larkin","raw_affiliation_strings":["10Royal Marsden NHS Foundation Trust, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"10Royal Marsden NHS Foundation Trust, London, United Kingdom","institution_ids":["https://openalex.org/I1325846038"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018384442","display_name":"Simon Pacey","orcid":"https://orcid.org/0000-0002-3303-7577","observed_orcids":["https://orcid.org/0000-0002-3303-7577"]},"institutions":[{"id":"https://openalex.org/I241749","display_name":"University of Cambridge","ror":"https://ror.org/013meh722","country_code":"GB","type":"education","lineage":["https://openalex.org/I241749"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Simon Pacey","raw_affiliation_strings":["11University of Cambridge, Department of Oncology, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"11University of Cambridge, Department of Oncology, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I241749"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111972597","display_name":"Miro Venturi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210094361","display_name":"Roche Pharma AG (Germany)","ror":"https://ror.org/00sh68184","country_code":"DE","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I4210094361"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Miro Venturi","raw_affiliation_strings":["12Pharma Research and Early Development, Oncology, Roche Penzberg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"12Pharma Research and Early Development, Oncology, Roche Penzberg, Germany","institution_ids":["https://openalex.org/I4210094361"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002836262","display_name":"Fran\u00e7oise Kraeber\u2010Bod\u00e9r\u00e9","orcid":"https://orcid.org/0000-0002-3417-0759","observed_orcids":["https://orcid.org/0000-0002-3417-0759"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Fran\u00e7oise Kraeber-Bod\u00e9r\u00e9","raw_affiliation_strings":["13Nuclear Medicine Department, H\u00f4tel-Dieu University Hospital, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"13Nuclear Medicine Department, H\u00f4tel-Dieu University Hospital, Nantes, France","institution_ids":["https://openalex.org/I3019204325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037380188","display_name":"Jean J. L. Tessier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean J.L. Tessier","raw_affiliation_strings":["14Pharma Research and Early Development, Oncology, Roche, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Pharma Research and Early Development, Oncology, Roche, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071766547","display_name":"Wilfried Eberhardt","orcid":"https://orcid.org/0000-0003-4284-3586","observed_orcids":["https://orcid.org/0000-0003-4284-3586"]},"institutions":[{"id":"https://openalex.org/I4210089079","display_name":"Ruhrlandklinik","ror":"https://ror.org/006c8a128","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210089079"]},{"id":"https://openalex.org/I4210119759","display_name":"Essen University Hospital","ror":"https://ror.org/02na8dn90","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210119759"]},{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Wilfried Ernst Erich Eberhardt","raw_affiliation_strings":["15Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Ruhrlandklinik, University Duisburg-Essen, Essen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"15Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Ruhrlandklinik, University Duisburg-Essen, Essen, Germany","institution_ids":["https://openalex.org/I4210089079","https://openalex.org/I4210119759","https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020250641","display_name":"Michel P\u00e2ques","orcid":"https://orcid.org/0000-0002-9102-9196","observed_orcids":["https://orcid.org/0000-0002-9102-9196"]},"institutions":[{"id":"https://openalex.org/I2801203653","display_name":"Centre hospitalier national d'ophtalmologie des Quinze-Vingts","ror":"https://ror.org/024v1ns19","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2801203653"]},{"id":"https://openalex.org/I4387154922","display_name":"Centre d'investigation clinique Quinze-Vingts","ror":"https://ror.org/01exas502","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4387154922"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Michel Paques","raw_affiliation_strings":["16Clinical Investigation Center 1423, Quinze-Vingts Hospital, Paris 6 University, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"16Clinical Investigation Center 1423, Quinze-Vingts Hospital, Paris 6 University, Paris, France","institution_ids":["https://openalex.org/I2801203653","https://openalex.org/I4387154922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081322213","display_name":"Ernesto Guarin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ernesto Guarin","raw_affiliation_strings":["14Pharma Research and Early Development, Oncology, Roche, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Pharma Research and Early Development, Oncology, Roche, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066708720","display_name":"Val\u00e9rie M\u00e9resse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Valerie Meresse","raw_affiliation_strings":["14Pharma Research and Early Development, Oncology, Roche, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"14Pharma Research and Early Development, Oncology, Roche, Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021624793","display_name":"Jean\u2010Charles Soria","orcid":"https://orcid.org/0000-0001-9597-0701","observed_orcids":["https://orcid.org/0000-0001-9597-0701"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Charles Soria","raw_affiliation_strings":["17SITEP, Gustave Roussy Cancer Center, University Paris-Sud, Villejuif, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"17SITEP, Gustave Roussy Cancer Center, University Paris-Sud, Villejuif, Paris, France","institution_ids":["https://openalex.org/I2801843802"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":22,"corresponding_author_ids":["https://openalex.org/A5071766547"],"corresponding_institution_ids":["https://openalex.org/I4210089079","https://openalex.org/I4210119759","https://openalex.org/I62318514"],"apc_list":null,"apc_paid":null,"fwci":3.5561,"has_fulltext":false,"cited_by_count":79,"citation_normalized_percentile":{"value":0.9470153,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"20","issue":"16","first_page":"4251","last_page":"4261"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9679999947547913},{"id":"https://openalex.org/keywords/ras-raf-mutations","display_name":"RAS/RAF mutations","score":0.8399999737739563},{"id":"https://openalex.org/keywords/braf-mutant-melanoma","display_name":"BRAF-mutant melanoma","score":0.9110000133514404},{"id":"https://openalex.org/keywords/kras-mutant-non-small-cell-lung-cancer","display_name":"KRAS-mutant non-small cell lung cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/kras-mutant-colorectal-cancer","display_name":"KRAS-mutant colorectal cancer","score":0.996999979019165},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9079999923706055},{"id":"https://openalex.org/keywords/ki-67","display_name":"Ki-67","score":0.9789999723434448},{"id":"https://openalex.org/keywords/pik3ca","display_name":"PIK3CA","score":0.7509999871253967},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.7279999852180481},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6209999918937683},{"id":"https://openalex.org/keywords/acneiform-dermatitis","display_name":"acneiform dermatitis","score":0.5899999737739563},{"id":"https://openalex.org/keywords/fdg-uptake","display_name":"FDG uptake","score":0.8330000042915344}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9099546670913696},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7829810380935669},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.7328097820281982},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7136043310165405},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.6701534986495972},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6556687355041504},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5727810859680176},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.496692955493927},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49491041898727417},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.4785780906677246},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.47600850462913513},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.43598243594169617},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.42390185594558716},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4216727614402771},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.36123645305633545},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.253948450088501},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.1685938537120819},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.13836759328842163},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.11632341146469116},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004252","descriptor_name":"DNA Mutational Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010078","descriptor_name":"Oxazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011518","descriptor_name":"Proto-Oncogene Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016283","descriptor_name":"Proto-Oncogene Proteins p21(ras)","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018631","descriptor_name":"ras Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020930","descriptor_name":"MAP Kinase Kinase Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D048493","descriptor_name":"Proto-Oncogene Proteins B-raf","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-14-0341","doi":"https://doi.org/10.1158/1078-0432.ccr-14-0341","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-14-0341","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:24947927","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24947927","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Clinical Trial, Phase I"},{"id":"pmh:oai:bibliographie.ub.uni-due.de:ubo_mods_00066963","doi":null,"is_oa":false,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pubmed/24947927","pdf_url":null,"source":{"id":"https://openalex.org/S7407055102","display_name":"Universit\u00e4tsbibliographie, Universit\u00e4t Duisburg-Essen","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"pmh:oai:dspace.library.uu.nl:1874/308528","doi":null,"is_oa":false,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/308528","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1547515123","https://openalex.org/W1766682057","https://openalex.org/W1988379285","https://openalex.org/W2000767539","https://openalex.org/W2009494242","https://openalex.org/W2011826559","https://openalex.org/W2019607817","https://openalex.org/W2066393891","https://openalex.org/W2070932010","https://openalex.org/W2073083472","https://openalex.org/W2081122128","https://openalex.org/W2097995306","https://openalex.org/W2099780734","https://openalex.org/W2100738068","https://openalex.org/W2101624426","https://openalex.org/W2101653483","https://openalex.org/W2107484016","https://openalex.org/W2108517627","https://openalex.org/W2108549165","https://openalex.org/W2110528825","https://openalex.org/W2114784462","https://openalex.org/W2118549562","https://openalex.org/W2118982164","https://openalex.org/W2120203403","https://openalex.org/W2122476809","https://openalex.org/W2123363005","https://openalex.org/W2128542677","https://openalex.org/W2129400742","https://openalex.org/W2130979878","https://openalex.org/W2131905520","https://openalex.org/W2136474966","https://openalex.org/W2141830999","https://openalex.org/W2143163879","https://openalex.org/W2144096834","https://openalex.org/W2147277119","https://openalex.org/W2154841567","https://openalex.org/W2156078931","https://openalex.org/W2156509877","https://openalex.org/W2157232767","https://openalex.org/W2159594827","https://openalex.org/W2160834915","https://openalex.org/W2164996207","https://openalex.org/W2165280661","https://openalex.org/W2166262263","https://openalex.org/W2183700222","https://openalex.org/W2255227919","https://openalex.org/W2328484078","https://openalex.org/W4234185004","https://openalex.org/W4247541485"],"related_works":["https://openalex.org/W2590829569","https://openalex.org/W2130979878","https://openalex.org/W2591414794","https://openalex.org/W2084184238","https://openalex.org/W2015603611","https://openalex.org/W4409821591","https://openalex.org/W2064969209","https://openalex.org/W2590312652","https://openalex.org/W1988379285","https://openalex.org/W1973794173"],"abstract_inverted_index":{"PURPOSE:":[0],"This":[1],"phase":[2,32],"I":[3,33],"expansion":[4,47],"study":[5,35],"assessed":[6],"safety,":[7],"pharmacodynamic":[8],"effects,":[9,85],"and":[10,38,56,89,93,101,123,136,160,201,210,247],"antitumor":[11],"activity":[12,234,250],"of":[13,67,82,144,155,163,225,244,257],"RO4987655,":[14,111],"a":[15,30,194],"pure":[16],"MEK":[17,231],"inhibitor,":[18],"in":[19,188,196,237],"selected":[20],"patients":[21,109],"with":[22,59,229],"advanced":[23],"solid":[24],"tumor.":[25],"EXPERIMENTAL":[26],"DESIGN:":[27],"We":[28],"undertook":[29],"multicenter":[31],"two-part":[34],"(dose":[36],"escalation":[37],"cohort":[39],"expansion).":[40],"Here,":[41],"we":[42],"present":[43],"the":[44],"part":[45],"2":[46],"that":[48],"included":[49],"melanoma,":[50,115,119],"non-small":[51],"cell":[52],"lung":[53],"cancer":[54,58,170],"(NSCLC),":[55],"colorectal":[57,126,169,217,241],"oral":[60],"RO4987655":[61,226],"administered":[62],"continuously":[63],"at":[64],"recommended":[65],"doses":[66],"8.5":[68],"mg":[69],"twice":[70],"daily":[71],"until":[72],"progressive":[73],"disease":[74],"(PD).":[75],"Sequential":[76],"tumor":[77,103,174],"sampling":[78],"investigated":[79],"multiple":[80],"markers":[81],"pathway":[83],"activation/tumor":[84],"including":[86,112],"ERK":[87,178],"phosphorylation":[88,179],"Ki-67":[90,189],"expression.":[91],"BRAF":[92,117,157],"KRAS":[94],"testing":[95],"were":[96,132],"implemented":[97],"as":[98,151],"selection":[99],"criteria":[100],"broader":[102],"mutational":[104,205,258],"analysis":[105],"added.":[106],"RESULTS:":[107],"Ninety-five":[108],"received":[110],"18":[113,164],"BRAF-mutant":[114],"23":[116],"wild-type":[118,158],"24":[120],"KRAS-mutant":[121,125,165,168],"NSCLC,":[122],"30":[124],"cancer.":[127,242],"Most":[128],"frequent":[129],"adverse":[130],"events":[131],"rash,":[133],"acneiform":[134],"dermatitis,":[135],"gastrointestinal":[137],"disorders,":[138],"mostly":[139],"grade":[140],"1/2.":[141],"Four":[142],"(24%)":[143],"17":[145],"BRAF-mutated":[146],"melanoma":[147,159],"had":[148],"partial":[149],"response":[150],"did":[152],"four":[153],"(20%)":[154],"20":[156],"two":[161],"(11%)":[162],"NSCLC.":[166],"All":[167],"developed":[171],"PD.":[172],"Paired":[173],"biopsies":[175],"demonstrated":[176],"reduced":[177],"among":[180,186,253],"all":[181,238,254],"cohorts":[182,187],"but":[183],"significant":[184],"differences":[185],"modulation.":[190],"Sixty-nine":[191],"percent":[192],"showed":[193],"decrease":[195],"fluorodeoxyglucose":[197],"uptake":[198],"between":[199],"baseline":[200],"day":[202],"15.":[203],"Detailed":[204],"profiling":[206],"confirmed":[207],"RAS/RAF":[208],"screening":[209],"identified":[211],"additional":[212],"aberrations":[213],"(NRAS/non-BRAF":[214],"melanomas;":[215],"PIK3CA/KRAS":[216],"cancer)":[218],"without":[219],"therapeutic":[220],"implications.":[221],"CONCLUSIONS:":[222],"Safety":[223],"profile":[224],"was":[227,235,251],"comparable":[228],"other":[230],"inhibitors.":[232],"Single-agent":[233],"observed":[236],"entities":[239],"except":[240],"Evidence":[243],"target":[245],"modulation":[246],"early":[248],"biologic":[249],"shown":[252],"indications":[255],"independent":[256],"status.":[259],"Clin":[260],"Cancer":[261],"Res;":[262],"20(16);":[263],"4251-61.":[264],"\u00a92014":[265],"AACR.":[266]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2054913636","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
